Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2017, Article ID 9642027, 9 pages
https://doi.org/10.1155/2017/9642027
Research Article

Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia

1Unified Women’s Clinical Research, 1100-C South Stratford Road, Suite 310, Winston-Salem, NC 27103, USA
2Luitpold Pharmaceuticals, Inc., 800 Adams Ave, Suite 100, Norrisville, PA 19403, USA
3Department of Obstetrics and Gynecology, Temple University School of Medicine, Philadelphia, PA 19140, USA

Correspondence should be addressed to Melvin H. Seid; moc.chdeifinu@dies.nivlem

Received 7 November 2016; Revised 17 February 2017; Accepted 21 February 2017; Published 13 April 2017

Academic Editor: Duran Canatan

Copyright © 2017 Melvin H. Seid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Richard P. Allen, Daniel L. Picchietti, Michael Auerbach, Yong Won Cho, James R. Connor, Christopher J. Earley, Diego Garcia-Borreguero, Suresh Kotagal, Mauro Manconi, William Ondo, Jan Ulfberg, and John W. Winkelman, “Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: An IRLSSG task force report,” Sleep Medicine, 2017. View at Publisher · View at Google Scholar
  • Lesley J. Scott, “Ferric Carboxymaltose: A Review in Iron Deficiency,” Drugs, 2018. View at Publisher · View at Google Scholar
  • Katsuya Ikuta, Asami Shimura, Hideki Hanashi, Kozo Hirai, Yoshiaki Ota, Yutaka Matsuyama, Masaru Terauchi, and Mikio Momoeda, “Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study,” International Journal of Hematology, 2018. View at Publisher · View at Google Scholar